186 related articles for article (PubMed ID: 3889629)
1. Fate of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in Sprague-Dawley rats. I. Mutagens in the urine.
Barnes WS; Weisburger JH
Mutat Res; 1985; 156(1-2):83-91. PubMed ID: 3889629
[TBL] [Abstract][Full Text] [Related]
2. Identification of the cooked food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and its N-acetylated and 3-N-demethylated metabolites in rat urine.
Peleran JC; Rao D; Bories GF
Toxicology; 1987 Feb; 43(2):193-9. PubMed ID: 3810661
[TBL] [Abstract][Full Text] [Related]
3. Mutagenic activity of three synthetic isomers of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in the Ames test.
Vikse R; Klungsøyr L; Grivas S
Mutat Res; 1993 Dec; 319(4):273-8. PubMed ID: 7504200
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin H synthase-dependent formation of the direct-acting mutagen 2-nitro-3-methylimidazo[4,5-f]quinoline (nitro-IQ) from IQ.
Morrison LD; Eling TE; Josephy PD
Mutat Res; 1993 May; 302(1):45-52. PubMed ID: 7683106
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the mutagenic effects of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) in bacteria with rat-liver 9000 x g supernatant or monolayers of rat hepatocytes as an activation system.
Holme JA; Brunborg G; Alexander J; Trygg B; Bjørnstad C
Mutat Res; 1988 Jan; 197(1):39-49. PubMed ID: 3275882
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin-H synthase mediated metabolism and mutagenic activation of 2-amino-3-methylimidazo [4,5-f] quinoline (IQ).
Wolz E; Wild D; Degen GH
Arch Toxicol; 1995; 69(3):171-9. PubMed ID: 7717873
[TBL] [Abstract][Full Text] [Related]
7. Genotoxicity of the food mutagen 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and analogs.
Barnes WS; Lovelette CA; Tong C; Williams GM; Weisburger JH
Carcinogenesis; 1985 Mar; 6(3):441-4. PubMed ID: 3884172
[TBL] [Abstract][Full Text] [Related]
8. Chemical structure and mutagenic activity of aminoimidazoquinolines and aminonaphthimidazoles related to 2-amino-3-methylimidazo[4,5-f]quinoline.
Kaiser G; Harnasch D; King MT; Wild D
Chem Biol Interact; 1986 Jan; 57(1):97-106. PubMed ID: 3512112
[TBL] [Abstract][Full Text] [Related]
9. Chlorophyllin-enhanced excretion of urinary and fecal mutagens in rats given 2-amino-3-methylimidazo[4,5-f]quinoline.
Dashwood R; Liew C
Environ Mol Mutagen; 1992; 20(3):199-205. PubMed ID: 1396610
[TBL] [Abstract][Full Text] [Related]
10. Genotoxic activity of the N-acetylated metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ).
Brunborg G; Holme JA; Alexander J; Becher G; Hongslo JK
Mutagenesis; 1988 Jul; 3(4):303-9. PubMed ID: 3062317
[TBL] [Abstract][Full Text] [Related]
11. Effect of tryptamine on the mutagenic activity of 2-amino-3-methylimidazo(4,5-f) quinoline (IQ) and related azaarenes in the Ames test.
Abu-Shakra A; Ioannides C; Walker R
Mutagenesis; 1987 Jan; 2(1):51-6. PubMed ID: 3331694
[TBL] [Abstract][Full Text] [Related]
12. Effect of methyl substitution on mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline, isolated from broiled sardine.
Nagao M; Wakabayashi K; Kasai H; Nishimura S; Sugimura T
Carcinogenesis; 1981; 2(11):1147-9. PubMed ID: 7032742
[TBL] [Abstract][Full Text] [Related]
13. Activation of the food mutagens IQ and MeIQ by hepatic S9 fractions derived from various species.
Alldrick AJ; Rowland IR
Mutat Res; 1985 Oct; 144(2):59-62. PubMed ID: 3900706
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay.
Snyderwine EG; Welti DH; Fay LB; Würzner HP; Turesky RJ
Chem Res Toxicol; 1992; 5(6):843-51. PubMed ID: 1489936
[TBL] [Abstract][Full Text] [Related]
15. Differential mutagenic activity of IQ (2-amino-3-methylimidazo[4,5-f]quinoline) in Salmonella typhimurium strains in vitro and in vivo, in Drosophila, and in mice.
Wild D; Gocke E; Harnasch D; Kaiser G; King MT
Mutat Res; 1985; 156(1-2):93-102. PubMed ID: 3923347
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 2-amino-3-methylimidazo[4,5-f]quinoline in the male rat.
Inamasu T; Luks H; Vavrek MT; Weisburger JH
Food Chem Toxicol; 1989 Jun; 27(6):369-76. PubMed ID: 2792966
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences.
Abu-Shakra A; Ioannides C; Walker R
Mutagenesis; 1986 Sep; 1(5):367-70. PubMed ID: 3331675
[TBL] [Abstract][Full Text] [Related]
18. Impact of aqueous doash extract on urinary mutagenicity in rats exposed to heterocyclic amines.
Khan JA; Jalal JA; Ioanndes C; Moselhy SS
Toxicol Ind Health; 2013 Mar; 29(2):142-8. PubMed ID: 22173956
[TBL] [Abstract][Full Text] [Related]
19. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
Edenharder R; Rauscher R; Platt KL
Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the mutagen 2-amino-3-methylimidazo[4,5-f]quinoline prepared from a 2-methylpyridine/creatinine/acetylformaldehyde model system.
Lee H; Lin MY; Lin ST
Mutagenesis; 1994 Mar; 9(2):157-62. PubMed ID: 8201949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
